In Vitro Anti‐Toxoplasma gondii Activity Evaluation of a New Series of Quinazolin‐4(3H)‐one Derivatives

Yu Deng, Hao Mu, Hong‐Bo Li, Lizhi Fu, Da Tang, Tao Wu, Shuheng Huang, Chenghong LiChemistry 2021 · DOI

Abstract

Toxoplasmosis post serious threaten to human health, leading to severely eye and brain disease, especially for immunocompromised patients and pregnant women. The multiple side effects and long dosing period of current main treatment regiments calls for high effective and low toxicity anti-toxoplasmosis drugs. Herein, we report our efforts to synthesize a series of 2-(piperazin-1-yl)quinazolin-4(3H)-one derivatives and investigate their activity against Toxoplasma gondii tachyzoites in vitro based on cell phenotype screening. Among the 26 compounds, 8w and 8x with diaryl ether moiety at the side chain of piperazine exhibited good efficacy to inhibit T. gondii, with IC<sub>50</sub> values of 4 μM and 3 μM, respectively. Structure-activity relationship (SAR) studies implies that hydrophobic aryl at the side chain would be preferred for improvement of activity. Molecular docking study reveals these two compounds appeared high affinity to TgCDPK1 by interaction with the hydrophobic pocket of ATP-binding cleft.
BibTeX
@inproceedings{deng2021i,
  author = {Yu Deng and Hao Mu and Hong‐Bo Li and Lizhi Fu and Da Tang and Tao Wu and Shuheng Huang and Chenghong Li},
  title = {{<i>In Vitro</i> Anti‐<i>Toxoplasma gondii</i> Activity Evaluation of a New Series of Quinazolin‐4(3<i>H</i>)‐one Derivatives}},
  booktitle = {Chemistry},
  year = {2021},
  doi = {10.1002/cbdv.202100687},
}

Loading related content...

Figure